Body and Brain Home-Based vs 9Round

9Round is the sharper near-term target purely because its installed base gives you a real addressable market right now. At 141 franchised units, you can run a repeatable outbound motion—143 doors to sell into if you include the corporate location—and the $160K–$390K investment range signals owners who’ve committed real capital and likely have operating budgets that can absorb a POS or marketing automation deal. Body and Brain’s six-unit network instantly caps pipeline at a handful of deals, and the $20K–$36K investment floor points to micro-entrepreneurs with barely enough margin for a scheduling tool, let alone a full back-office stack. Both brands use an approved-supplier model, so terrain is equally accessible, but that advantage only matters where there are enough units to matter.

The tradeoff that kills the default TAM argument is timing. 9Round’s unit count is imploding at a −29% year-over-year rate; you’re not selling into a growing fleet but monetizing a shrinking one. Every month you delay, your addressable base contracts, and franchisees in a declining system get conservative with tech spend. This doesn’t erase the relative advantage—Body and Brain’s tiny count makes it a no-go for any vendor needing scale—but it does mean your revenue window is finite. You must capture value fast, treat this as a liquidation of the installed base, and have no expectation of organic growth from new openings.

Budget and TAM pick 9Round; timing is a deliberate risk you take for that TAM. Terrain is a tie. If you’ve got the sales capacity to work 141 accounts before another 30–40 of them shutter, the per-unit deal potential makes this a better gamble than chasing six low-budget operators.

Verdict: 9Round wins on TAM and buyer budget, but you’re selling into a structural decline, so speed is the real differentiator.